49 related articles for article (PubMed ID: 23642739)
1. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence.
Tsourlakis MC; Schoop M; Plass C; Huland H; Graefen M; Steuber T; Schlomm T; Simon R; Sauter G; Sirma H; Minner S
Hum Pathol; 2013 Sep; 44(9):1789-96. PubMed ID: 23642739
[TBL] [Abstract][Full Text] [Related]
2. Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.
Tomlins SA; Alshalalfa M; Davicioni E; Erho N; Yousefi K; Zhao S; Haddad Z; Den RB; Dicker AP; Trock BJ; DeMarzo AM; Ross AE; Schaeffer EM; Klein EA; Magi-Galluzzi C; Karnes RJ; Jenkins RB; Feng FY
Eur Urol; 2015 Oct; 68(4):555-67. PubMed ID: 25964175
[TBL] [Abstract][Full Text] [Related]
3. HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.
Smith SC; Palanisamy N; Zuhlke KA; Johnson AM; Siddiqui J; Chinnaiyan AM; Kunju LP; Cooney KA; Tomlins SA
Am J Surg Pathol; 2014 May; 38(5):615-26. PubMed ID: 24722062
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study of ERG expression and the relationship with clinicopathological features of Prostate cancer in Southwestern Uganda.
Mitala Y; Ssenkumba B; Birungi A; Kiconco R; Mutakooha MM; Atwine R
Diagn Pathol; 2024 May; 19(1):67. PubMed ID: 38730435
[TBL] [Abstract][Full Text] [Related]
5. FGFR1 and WT1 are markers of human prostate cancer progression.
Devilard E; Bladou F; Ramuz O; Karsenty G; Dalès JP; Gravis G; Nguyen C; Bertucci F; Xerri L; Birnbaum D
BMC Cancer; 2006 Nov; 6():272. PubMed ID: 17137506
[TBL] [Abstract][Full Text] [Related]
6. Publisher Correction: PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.
Benitez JA; Ma J; D'Antonio M; Boyer A; Camargo MF; Zanca C; Kelly S; Khodadadi-Jamayran A; Jameson NM; Andersen M; Miletic H; Saberi S; Frazer KA; Cavenee WK; Furnari FB
Nat Commun; 2018 May; 9():16217. PubMed ID: 29799523
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia.
Pergaris A; Genaris I; Stergiou IE; Klijanienko J; Papadakos SP; Theocharis S
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958340
[TBL] [Abstract][Full Text] [Related]
8. Regulation of SUMOylation on RNA metabolism in cancers.
Cao Y; Huang C; Zhao X; Yu J
Front Mol Biosci; 2023; 10():1137215. PubMed ID: 36911524
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal regulation of Daxx and PIK3CA promotes colorectal cancer cell growth.
Huang YS; Wu CC; Chang CC; Huang SF; Kuo HY; Shih HM
Cell Mol Life Sci; 2022 Jun; 79(7):367. PubMed ID: 35718818
[TBL] [Abstract][Full Text] [Related]
10. Solid tumours hijack the histone variant network.
Ghiraldini FG; Filipescu D; Bernstein E
Nat Rev Cancer; 2021 Apr; 21(4):257-275. PubMed ID: 33568791
[TBL] [Abstract][Full Text] [Related]
11. Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma.
Davidson B; McFadden E; Holth A; Brunetti M; Flørenes VA
Virchows Arch; 2020 Dec; 477(6):857-864. PubMed ID: 32533344
[TBL] [Abstract][Full Text] [Related]
12. Association of Mental Health-Related Proteins DAXX, DRD3, and DISC1 With the Progression and Prognosis of Chondrosarcoma.
He L; Shi X; Chen R; Wu Z; Yang Z; Li Z
Front Mol Biosci; 2019; 6():134. PubMed ID: 31850367
[TBL] [Abstract][Full Text] [Related]
13. DAXX in cancer: phenomena, processes, mechanisms and regulation.
Mahmud I; Liao D
Nucleic Acids Res; 2019 Sep; 47(15):7734-7752. PubMed ID: 31350900
[TBL] [Abstract][Full Text] [Related]
14. Centromeric and ectopic assembly of CENP-A chromatin in health and cancer: old marks and new tracks.
Sharma AB; Dimitrov S; Hamiche A; Van Dyck E
Nucleic Acids Res; 2019 Feb; 47(3):1051-1069. PubMed ID: 30590707
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Implications of Death Domain-Associated Protein (DAXX) Expression.
Ko TY; Kim JI; Park ES; Mun JM; Park SD
Korean J Thorac Cardiovasc Surg; 2018 Jun; 51(3):187-194. PubMed ID: 29854663
[TBL] [Abstract][Full Text] [Related]
16. Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer.
Burdelski C; Borcherding L; Kluth M; Hube-Magg C; Melling N; Simon R; Möller-Koop C; Weigand P; Minner S; Haese A; Michl HU; Tsourlakis MC; Jacobsen F; Hinsch A; Wittmer C; Lebok P; Steurer S; Izbicki JR; Sauter G; Krech T; Büscheck F; Clauditz T; Schlomm T; Wilczak W
Oncotarget; 2017 May; 8(19):31494-31508. PubMed ID: 28415558
[TBL] [Abstract][Full Text] [Related]
17. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
[TBL] [Abstract][Full Text] [Related]
18. A New Combinatorial Optimization Approach for Integrated Feature Selection Using Different Datasets: A Prostate Cancer Transcriptomic Study.
Puthiyedth N; Riveros C; Berretta R; Moscato P
PLoS One; 2015; 10(6):e0127702. PubMed ID: 26106884
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of Autophagy.
Puto LA; Brognard J; Hunter T
J Biol Chem; 2015 Jun; 290(25):15406-15420. PubMed ID: 25903140
[TBL] [Abstract][Full Text] [Related]
20. HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy.
Zabalza CV; Adam M; Burdelski C; Wilczak W; Wittmer C; Kraft S; Krech T; Steurer S; Koop C; Hube-Magg C; Graefen M; Heinzer H; Minner S; Simon R; Sauter G; Schlomm T; Tsourlakis MC
Oncotarget; 2015 May; 6(14):12822-34. PubMed ID: 25825985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
